Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
MARKETS
Biolinerx (blrx) stock soars on liver drug licensing agreement
By Annie Palmer
Sep 23, 2016 3:39 PM EDT
PRESS RELEASES
BioLineRx Announces Initiation Of Phase 1b Clinical Trial In Patients With Acute Respiratory Distress Syndrome (ARDS) Secondary To COVID-19 And Other Respiratory Viral Infections
By PR Newswire
Nov 18, 2020 7:00 AM EST
PRESS RELEASES
BioLineRx To Report Third Quarter 2020 Results On November 23, 2020
By PR Newswire
Nov 18, 2020 7:00 AM EST
PRESS RELEASES
BioLineRx Announces Positive Results From Interim Analysis Of GENESIS Phase 3 Trial Of Motixafortide (BL-8040) In Stem Cell Mobilization
By PR Newswire
Oct 30, 2020 7:00 AM EDT
PRESS RELEASES
BioLineRx Announces Initiation Of Phase 2 Clinical Trial In First-Line Metastatic Pancreatic Cancer
By PR Newswire
Oct 29, 2020 8:48 AM EDT
PRESS RELEASES
BioLineRx Achieves Enrollment Target In Phase 3 GENESIS Trial For Planned Interim Analysis
By PR Newswire
Aug 19, 2020 7:00 AM EDT
PRESS RELEASES
BioLineRx To Report Second Quarter 2020 Results On August 6, 2020
By PR Newswire
Jul 31, 2020 7:00 AM EDT
PRESS RELEASES
BioLineRx Announces $4.39 Million Registered Direct Offering
By PR Newswire
Jun 1, 2020 8:00 AM EDT
PRESS RELEASES
BioLineRx Announces $9.0 Million Registered Direct Offering
By PR Newswire
May 26, 2020 8:40 AM EDT
PRESS RELEASES
BioLineRx To Report First Quarter 2020 Results On May 20, 2020
By PR Newswire
May 15, 2020 7:00 AM EDT
PRESS RELEASES
BioLineRx Announces Notice Of Allowance From USPTO For Patent Covering Motixafortide (BL-8040) In Combination With Anti-PD-1 For The Treatment Of Any Type Of Cancer
By PR Newswire
Feb 27, 2020 7:43 AM EST
PRESS RELEASES
BioLineRx Completes Recruitment In Triple Combination Arm Of COMBAT/KEYNOTE-202 Study In Patients With Second-line Metastatic Pancreatic Cancer
By PR Newswire
Jan 22, 2020 7:00 AM EST
PRESS RELEASES
BioLineRx Receives Orphan Drug Designation For Motixafortide (BL-8040) For The Treatment Of Pancreatic Cancer In Europe
By PR Newswire
Jan 14, 2020 7:00 AM EST
PRESS RELEASES
BioLineRx To Present At The 2020 Biotech Showcase
By PR Newswire
Jan 8, 2020 7:00 AM EST
MARKETS
Biolinerx (blrx) stock soars on liver drug licensing agreement
By Annie Palmer
Sep 23, 2016 3:39 PM EDT
OPINION
7 stocks under $10 to trade for big profits
By Roberto Pedone
May 6, 2016 8:29 AM EDT
OPINION
These 7 stocks under $10 are making big moves to the upside
By Roberto Pedone
Apr 15, 2016 7:59 AM EDT
MARKETS
BioLineRx (BLRX) Stock Down on Negative Heart Disease Treatment Results
By Tony Owusu
Jul 27, 2015 10:49 AM EDT
MARKETS
Bioline RX (BLRX) Stock Gains on Positive Test Results, Coverage Initiation
By Tony Owusu
Jun 22, 2015 1:30 PM EDT
INVESTING
4 Stocks Under $10 Making Big Moves
By Roberto Pedone
Apr 7, 2015 2:16 PM EDT
INVESTING
3 Stocks Under $10 Making Big Moves Higher
By Roberto Pedone
Mar 24, 2015 2:10 PM EDT
INVESTING
5 Stocks Under $10 Set to Soar
By Roberto Pedone
Apr 18, 2013 2:24 PM EDT
STOCKS
BioLineRx Shares Fall On Schizophrenia Drug Failure
By Adam Feuerstein
Mar 20, 2013 11:23 AM EDT
INVESTING
4 Stocks Under $5 Making Big Moves
By Roberto Pedone
Feb 22, 2013 3:21 PM EST
STOCKS
BioLineRx: Tuesday's Hot Hep C Drug Stock
By Adam Feuerstein
Jan 24, 2012 1:37 PM EST
